Approved comparison material connected to this topic.
3 total recordsSource comparisons are presented without a generated winner.
Branded Egrifta (retail pharmacy) $4,000–$5,500 60mg (2mg daily × 30 days) $66.67–$91.67/mg Full FDA approval as finished drug product Covered only for HIV-associated lipodystrophy Yes. Specialist prescriber t…
Brand-name Egrifta (tesamorelin acetate for injection) retails at $2,400 to $2,800 per month as of early 2026. This reflects the 2mg daily dosing protocol approved for HIV-associated lipodystrophy. Approximate…
Brand Egrifta (retail pharmacy) $2,400–$2,800 Yes (with PA) Yes FDA batch oversight Highest regulatory scrutiny but most expensive. Justified only when insurance covers majority of cost Brand Egrifta (specialt…